Longer Gap Between Doses Boosts Durability of Self-Amplifying mRNA H5N1 Flu Vaccine in Phase 1 Trial
A Phase 1 trial found that an eight-week dosing interval produced stronger and longer-lasting antibody responses against H5N1 influenza than ...
Tag: H5N1 influenza
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era